Figure 7.

The three-gene signature predicted survival of RCC patients. A. SurvExpress was used to analyze the association of the three-gene signature with the predicted risk, survival and prognosis. B. Kaplan-Meier survival curves showed that patients with a predicted high risk had significantly shorter OS than those with a low risk. C. The gene expression level of COL5A1, COL6A3 and COL11A1 was detected in high risk and low risk groups. The gene expression of COL5A1, COL6A3 and COL11A1 was higher in high risk group than that in low risk group.